# Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

> **NCT00466271** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 102 (actual)

## Conditions studied

- Chronic Hepatitis C
- Hepatic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00466271
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2008-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466271, "Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00466271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*